Study of factors influencing celiac disease in infants
Official title: Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study
Run by Massachusetts General Hospital · NCT02061306 · Data updated 2026-11-12
This study is trying to see how genetics and environmental factors affect the risk of celiac disease in infants who have a family member with the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 6 Months |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | March 2014 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT02061306 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are newborns and infants under six months of age with a first-degree relative diagnosed with celiac disease.
✕Probably not a fit
Infants older than six months or those without a family history of celiac disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CDGEMM study investigates the interplay of genomic, environmental, microbiome, and metabolomic factors in the development of celiac disease (CD) among infants. It focuses on newborns with a first-degree relative diagnosed with CD, examining how genetic predispositions and environmental influences, such as birth method and antibiotic use, contribute to disease risk. The study will follow these infants until they are five years old, collecting data on their health and dietary habits to identify potential predictors of CD. By understanding these factors, the study aims to enhance early detection and prevention strategies for high-risk children.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and early detection strategies for celiac disease in high-risk infants.
How similar studies have gone: Other studies have shown success in identifying genetic and environmental factors related to celiac disease, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newborns and infants less than 6 months of age who have not been introduced to solid foods (exclusive breast milk or formula diet) * First-degree relatives of patients affected with biopsy-proven CD Exclusion Criteria: * Infants older than 6 months of age * Inability or unwillingness of legal guardian/representative to give written informed consent
Where it's running
-
MassGeneral Hospital for Children
Boston, Massachusetts, United States Recruiting -
University of Roma La Sapienza
Rome, Italy Recruiting
Study contacts
- Principal investigator: Maureen Leonard, MD — Massachusetts General Hospital
- Study coordinator: Victoria Kenyon, MHA
- Email: vakenyon@mgb.org
- Phone: 617-643-4366
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.